NEUROONE MEDICAL TECHNOLOGIES Corp 8-K

What Happened

• NeuroOne Medical Technologies Corporation filed a Form 8-K on May 12, 2026 (Item 2.02) announcing its financial results for the fiscal quarter ended March 31, 2026.
• The company furnished a press release dated May 12, 2026 as Exhibit 99.1 to the Form 8-K; that press release is incorporated by reference into the filing.

Key Details

• Filing date: May 12, 2026 (Current Report on Form 8-K).
• Reporting item: Item 2.02 — Results of Operations and Financial Condition (quarterly financial results announced).
• Period covered: Fiscal quarter ended March 31, 2026.
• Exhibit included: Exhibit 99.1 — Press Release (dated May 12, 2026); the filing also includes the Cover Page Interactive Data File (Inline XBRL).

Why It Matters

• The filing signals that NeuroOne has released its latest quarterly earnings information; investors should review the press release for revenue, earnings, cash flow, and any company commentary or guidance.
• Because the 8-K furnishes the press release as formal disclosure, the information is material and part of the company’s public financial record — useful for shareholders evaluating recent performance or making investment decisions.
• Next step for investors: read Exhibit 99.1 (the press release) or the company’s investor relations page for the detailed financial figures and management commentary.